This mRNA vaccine could potentially prevent the deadliest form of skin cancer
Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert have more information.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
CBS News (www.cbsnews.com), a Tier B publisher, filed this report on .
Signal breakdown
CurrentWire ranked this story 61 of 100 in the snapshot this page was rendered from.
- Freshness
- 31.5 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 31.5 of 35. How each signal is calculated.
Filed under Health · International · News.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.